Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.
Artikel i vetenskaplig tidskrift, 2008

It is of great significance to find better markers to correctly distinguish between high-risk and low-risk breast cancer patients since the majority of breast cancer cases are at present being overtreated.

Follow-Up Studies

Kaplan-Meier Estimate

genetics

mortality

Biological

Female

Tumor Markers

genetics

Ductal

pathology

Humans

diagnosis

Breast

Gene Expression Profiling

Cluster Analysis

genetics

Predictive Value of Tests

Breast Neoplasms

Oligonucleotide Array Sequence Analysis

pathology

mortality

Lymphatic Metastasis

Carcinoma

diagnosis

Prognosis

Middle Aged

Författare

Elin Karlsson

Göteborgs universitet

Ulla Delle

Göteborgs universitet

Anna Danielsson

Göteborgs universitet

Björn Olsson

Frida Abel

Göteborgs universitet

Per Karlsson

Göteborgs universitet

Khalil Helou

Göteborgs universitet

BMC Cancer

1471-2407 (ISSN)

Vol. 8 254-

Ämneskategorier

Medicinska grundvetenskaper

Klinisk medicin

DOI

10.1186/1471-2407-8-254

PubMed

18778486

Mer information

Skapat

2017-10-10